std surveillance 2001 adapted from cdc by jill gallin, cpnp assistant professor of clinical nursing
Post on 21-Dec-2015
214 views
TRANSCRIPT
Factors affecting report data
• Reporting systems– Laboratories– Providers– Information systems
• Increase or decrease in screening
• Sensitivity of diagnostic tests/ Ability to diagnose disease
Chlamydia — Number of states that require reporting of Chlamydia trachomatis infections: United States, 1987–2001
No. of states
0
10
20
30
40
50
1987 88 89 90 91 92 93 94 95 96 97 98 99 2000 01
Chlamydia — Reported rates: United States, 1984–2001
Rate (per 100,000 population)
0
60
120
180
240
300
1984 86 88 90 92 94 96 98 2000
Chlamydia — Rates by state: United States and outlying areas, 2001
Note: The total rate of chlamydia for the United States and outlying areas (including Guam, Puerto Rico and Virgin Islands) was 275.5 per 100,000 population.
Rate per 100,000population
<=150150.1-300>300
VT 104.8 NH 111.9 MA 163.8 RI 277.8 CT 226.6 NJ 193.9 DE 356.4 MD 295.3
Guam 278.4
Puerto Rico 72.2 Virgin Is. 120.6
(n= 7)(n= 29)(n= 17)
326.6
437.7
279.6272.3
301.0 307.8
235.4
413.4
332.7
156.3
352.0 250.9
194.7
225.0219.7
399.2
104.9
312.8
169.2
414.6
249.3
212.7
187.3241.8
343.8
244.5
274.6
165.4
331.7
303.7
217.9
231.0
382.1
241.2
273.5
334.5
134.5
259.1
231.3
129.7
303.6
169.9
Chlamydia — Rates by region: United States, 1984–2001
Rate (per 100,000 population)
WestMidwestNortheastSouth
0
70
140
210
280
350
1984 86 88 90 92 94 96 98 2000
Chlamydia — Rates by sex: United States, 1984–2001
Rate (per 100,000 population)
MenWomen
0
90
180
270
360
450
1984 86 88 90 92 94 96 98 2000
Chlamydia — Age- and sex-specific rates: United States, 2001
Men Rate (per 100,000 population) Women
Age3,000 2,400 1,800 1,200 600 0 0 600 1,200 1,800 2,400 3,000
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14 9.9
Men Rate (per 100,000 population) Women
Age3,000 2,400 1,800 1,200 600 0 0 600 1,200 1,800 2,400 3,000
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14
375.9
Men Rate (per 100,000 population) Women
Age3,000 2,400 1,800 1,200 600 0 0 600 1,200 1,800 2,400 3,000
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14
604.9
Men Rate (per 100,000 population) Women
Age3,000 2,400 1,800 1,200 600 0 0 600 1,200 1,800 2,400 3,000
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14
284.7
Men Rate (per 100,000 population) Women
Age3,000 2,400 1,800 1,200 600 0 0 600 1,200 1,800 2,400 3,000
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14
140.4
Men Rate (per 100,000 population) Women
Age3,000 2,400 1,800 1,200 600 0 0 600 1,200 1,800 2,400 3,000
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14
70.3
Men Rate (per 100,000 population) Women
Age3,000 2,400 1,800 1,200 600 0 0 600 1,200 1,800 2,400 3,000
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14
37.1
Men Rate (per 100,000 population) Women
Age3,000 2,400 1,800 1,200 600 0 0 600 1,200 1,800 2,400 3,000
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14
15.9
Men Rate (per 100,000 population) Women
Age3,000 2,400 1,800 1,200 600 0 0 600 1,200 1,800 2,400 3,000
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14
5.5
Men Rate (per 100,000 population) Women
Age3,000 2,400 1,800 1,200 600 0 0 600 1,200 1,800 2,400 3,000
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14
2.2
Men Rate (per 100,000 population) Women
Age3,000 2,400 1,800 1,200 600 0 0 600 1,200 1,800 2,400 3,000
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14
114.2
Men Rate (per 100,000 population) Women
Age3,000 2,400 1,800 1,200 600 0 0 600 1,200 1,800 2,400 3,000
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14 139.8
Men Rate (per 100,000 population) Women
Age3,000 2,400 1,800 1,200 600 0 0 600 1,200 1,800 2,400 3,000
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14
2,536.1
Men Rate (per 100,000 population) Women
Age3,000 2,400 1,800 1,200 600 0 0 600 1,200 1,800 2,400 3,000
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14
2,447.0
Men Rate (per 100,000 population) Women
Age3,000 2,400 1,800 1,200 600 0 0 600 1,200 1,800 2,400 3,000
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14
824.6
Men Rate (per 100,000 population) Women
Age3,000 2,400 1,800 1,200 600 0 0 600 1,200 1,800 2,400 3,000
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14
301.9
Men Rate (per 100,000 population) Women
Age3,000 2,400 1,800 1,200 600 0 0 600 1,200 1,800 2,400 3,000
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14
119.1
Men Rate (per 100,000 population) Women
Age3,000 2,400 1,800 1,200 600 0 0 600 1,200 1,800 2,400 3,000
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14
51.4
Men Rate (per 100,000 population) Women
Age3,000 2,400 1,800 1,200 600 0 0 600 1,200 1,800 2,400 3,000
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14
18.1
Men Rate (per 100,000 population) Women
Age3,000 2,400 1,800 1,200 600 0 0 600 1,200 1,800 2,400 3,000
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14
5.1
Men Rate (per 100,000 population) Women
Age3,000 2,400 1,800 1,200 600 0 0 600 1,200 1,800 2,400 3,000
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14
2.9
Men Rate (per 100,000 population) Women
Age3,000 2,400 1,800 1,200 600 0 0 600 1,200 1,800 2,400 3,000
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14
436.3
Chlamydia — Trends in positivity among 15-44 year old women tested in family planning clinics by HHS regions, 1988–2001
Note: Trends adjusted for changes in laboratory test method and associated increases in test sensitivity. No data on laboratory test method available for Region VII in 1995 and Regions IV and V in 1996.
SOURCE: Regional Infertility Prevention Program; Office of Population Affairs; Local and State STD Control Programs; Centers for Disease Control and Prevention
IX
XVIII
VII
VI
V
IV
III
III
Region IRegion II
Region III
Region IV
Region V
Region VIRegion VII
Region VIII
Region IX
Region X 97 98 99 00 01
5.7 6.2 6.2 6.47.3
96 97 98 99 00 01
6.74.9 4.6 4.1 4.9 5.1
96 97 98 99 00 019594
7.46.0 5.3 5.6 6.0 6.3 6.0 5.5
97 98 99 00 01
8.910.1 9.5
8.6 8.5
97 98 99 00 01
5.6
7.5 7.2 7.1 6.6
96 97 98 99 00 01
8.4 8.9 9.78.7 8.8 8.5
96 97 98 99 00 01
4.9 4.7 5.4 5.3 5.5 5.4
96 97 98 99 00 0194 95
6.05.0 4.6 4.6 5.3 5.4 5.6 6.0
96 97 98 99 00 01
5.1 5.25.9 6.3 6.2 6.3
96 97 98 99 00 0194 95939291908988
13.0
10.0 9.58.0
6.75.0 4.7 4.1 3.9 3.9 4.6 4.9 5.3 5.3
Gonorrhea — Reported rates: United States, 1970–2001 and the Healthy People year 2010 objective
R ate (per 100,000 population)
G onorrhea2010 O bjective
0
100
200
300
400
500
1970 73 76 79 82 85 88 91 94 97 2000
Note: The Healthy People 2010 (HP2010) objective for gonorrhea is 19.0 cases per 100,000 population.
Gonorrhea — Rates by region: United States, 1981–2001 and the Healthy People year 2010 objective
R ate (per 100,000 population)
W estM idw estN ortheastSouth2010 O bjective
0
120
240
360
480
600
1981 83 85 87 89 91 93 95 97 99 2001
Gonorrhea — Rates by sex: United States, 1981–2001 and the Healthy People year 2010 objective
R ate (per 100,000 population)
M aleFem ale2010 O bjective
0
120
240
360
480
600
1981 83 85 87 89 91 93 95 97 99 2001
Gonorrhea — Rates by race and ethnicity: United States, 1981–2001 and the Healthy People year 2010 objective
R ate (per 100,000 population)
W hiteB lackH ispan icAsian/Pac Is lAm Ind /AK N at2010 O bjective
0
500
1,000
1,500
2,000
2,500
1981 83 85 87 89 91 93 95 97 99 2001
Gonorrhea — Age- and sex-specific rates: United States, 2001
M en R ate (per 100,000 population) W om en
Age750 600 450 300 150 0 0 150 300 450 600 750
Tota l 65+
55-64
45-5440-4435-39
30-3425-2920-2415-19
10-148.2
M en R ate (per 100,000 population) W om en
Age750 600 450 300 150 0 0 150 300 450 600 750
Tota l 65+
55-64
45-5440-4435-39
30-3425-2920-2415-19
10-14307.5
M en R ate (per 100,000 population) W om en
Age750 600 450 300 150 0 0 150 300 450 600 750
Tota l 65+
55-64
45-5440-4435-39
30-3425-2920-2415-19
10-14
563.6
M en R ate (per 100,000 population) W om en
Age750 600 450 300 150 0 0 150 300 450 600 750
Tota l 65+
55-64
45-5440-4435-39
30-3425-2920-2415-19
10-14
328.4
M en R ate (per 100,000 population) W om en
Age750 600 450 300 150 0 0 150 300 450 600 750
Tota l 65+
55-64
45-5440-4435-39
30-3425-2920-2415-19
10-14
203.9
M en R ate (per 100,000 population) W om en
Age750 600 450 300 150 0 0 150 300 450 600 750
Tota l 65+
55-64
45-5440-4435-39
30-3425-2920-2415-19
10-14
134.3
M en R ate (per 100,000 population) W om en
Age750 600 450 300 150 0 0 150 300 450 600 750
Tota l 65+
55-64
45-5440-4435-39
30-3425-2920-2415-19
10-14
90.5
M en R ate (per 100,000 population) W om en
Age750 600 450 300 150 0 0 150 300 450 600 750
Tota l 65+
55-64
45-5440-4435-39
30-3425-2920-2415-19
10-14
46.8
M en R ate (per 100,000 population) W om en
Age750 600 450 300 150 0 0 150 300 450 600 750
Tota l 65+
55-64
45-5440-4435-39
30-3425-2920-2415-19
10-14
17.2
M en R ate (per 100,000 population) W om en
Age750 600 450 300 150 0 0 150 300 450 600 750
Tota l 65+
55-64
45-5440-4435-39
30-3425-2920-2415-19
10-14
4.5
M en R ate (per 100,000 population) W om en
Age750 600 450 300 150 0 0 150 300 450 600 750
Tota l 65+
55-64
45-5440-4435-39
30-3425-2920-2415-19
10-14
128.6
M en R ate (per 100,000 population) W om en
Age750 600 450 300 150 0 0 150 300 450 600 750
Tota l 65+
55-64
45-5440-4435-39
30-3425-2920-2415-19
10-14 51.8
M en R ate (per 100,000 population) W om en
Age750 600 450 300 150 0 0 150 300 450 600 750
Tota l 65+
55-64
45-5440-4435-39
30-3425-2920-2415-19
10-14703.2
M en R ate (per 100,000 population) W om en
Age750 600 450 300 150 0 0 150 300 450 600 750
Tota l 65+
55-64
45-5440-4435-39
30-3425-2920-2415-19
10-14
664.1
M en R ate (per 100,000 population) W om en
Age750 600 450 300 150 0 0 150 300 450 600 750
Tota l 65+
55-64
45-5440-4435-39
30-3425-2920-2415-19
10-14
249.4
M en R ate (per 100,000 population) W om en
Age750 600 450 300 150 0 0 150 300 450 600 750
Tota l 65+
55-64
45-5440-4435-39
30-3425-2920-2415-19
10-14
112.7
M en R ate (per 100,000 population) W om en
Age750 600 450 300 150 0 0 150 300 450 600 750
Tota l 65+
55-64
45-5440-4435-39
30-3425-2920-2415-19
10-14
57.8
M en R ate (per 100,000 population) W om en
Age750 600 450 300 150 0 0 150 300 450 600 750
Tota l 65+
55-64
45-5440-4435-39
30-3425-2920-2415-19
10-14
31.2
M en R ate (per 100,000 population) W om en
Age750 600 450 300 150 0 0 150 300 450 600 750
Tota l 65+
55-64
45-5440-4435-39
30-3425-2920-2415-19
10-14
9.4
M en R ate (per 100,000 population) W om en
Age750 600 450 300 150 0 0 150 300 450 600 750
Tota l 65+
55-64
45-5440-4435-39
30-3425-2920-2415-19
10-14
2.0
M en R ate (per 100,000 population) W om en
Age750 600 450 300 150 0 0 150 300 450 600 750
Tota l 65+
55-64
45-5440-4435-39
30-3425-2920-2415-19
10-14
0.9
M en R ate (per 100,000 population) W om en
Age750 600 450 300 150 0 0 150 300 450 600 750
Tota l 65+
55-64
45-5440-4435-39
30-3425-2920-2415-19
10-14
128.5
Gonococcal Isolate Surveillance Project (GISP) — Location of participating clinics and regional laboratories: United States, 2001
Tripler AMC
Gonococcal Isolate Surveillance Project (GISP) — Penicillin and tetracycline resistance among GISP isolates, 2001
Note: PPNG=penicillinase-producing N. gonorrhoeae; TRNG=plasmid-mediated tetracycline resistant N. gonorrhoeae; PPNG-TRNG=plasmid-mediated penicillin and tetracycline resistant N. gonorrhoeae; PenR=chromosomally mediated penicillin resistant N. gonorrhoeae; TetR=chromosomally mediated tetracycline resistant N. gonorrhoeae; CMRNG=chromosomally mediated penicillin and tetracycline resistant N. gonorrhoeae.
S usceptib le
P P N G
TR N G
P P N G /TR N G
P enR
TetR
C M R N G
79.1%
1.5%
5.2%
0.5%2.9%
4.4%
6.4%
Gonococcal Isolate Surveillance Project (GISP) — Percent of Neisseria gonorrhoeae isolates with resistance or intermediate
resistance to ciprofloxacin, 1990–2001
Note: Resistant isolates have ciprofloxacin MICs >1 g/mL. Isolates with intermediate resistance have ciprofloxacin MICs of 0.125 - 0.5 g/mL. Susceptibility to ciprofloxacin was first measured in GISP in 1990.
Percent
R esistance
Interm ediate resistance
0.0
0.6
1.2
1.8
2.4
3.0
1990 91 92 93 94 95 96 97 98 99 2000 01
Syphilis — Reported cases by stage of illness: United States, 1941–2001
Thousands of cases
P&SEarly LatentTotal Syphilis
0
120
240
360
480
600
1941 46 51 56 61 66 71 76 81 86 91 96 2001
Primary and secondary syphilis — Reported rates: United States, 1970–2001 and the Healthy People year 2010 objective
Rate (per 100,000 population)
P&S Syphilis2010 Objective
0
5
10
15
20
25
1970 73 76 79 82 85 88 91 94 97 2000
Note: The Healthy People 2010 (HP2010) objective for primary and secondary syphilis is 0.2 case per 100,000 population.
Primary and secondary syphilis — Rates by state: United States and outlying areas, 2001
Note: The total rate of primary and secondary syphilis for the United States and outlying areas (including Guam, Puerto Rico and Virgin Islands) was 2.2 per 100,000 population. The Healthy People year 2010 objective is 0.2 per 100,000 population.
Rate per 100,000population
<=.2.21-4>4
VT 0.5 NH 0.1 MA 0.7 RI 0.9 CT 0.4 NJ 1.6 DE 1.8 MD 5.0
Guam 7.8
Puerto Rico 6.4 Virgin Is. 0.0
(n= 10)(n= 34)(n= 9)
3.2
0.0
3.5 1.8
1.6 0.5
3.0
5.1
1.0
0.1
3.3 2.5
0.2
0.9 1.2
3.9
0.1
4.3
0.7
4.9
0.5
0.0
0.6 0.4
1.0
1.6
5.5
0.0
0.7
1.7
0.4
0.8
5.9
0.1
5.8
2.3
0.5
1.4
1.0
0.3
0.4
0.2
Primary and secondary syphilis — Rates by region: United States, 1981–2001 and the Healthy People year 2010 objective
Rate (per 100,000 population)
WestMidwestNortheastSouth2010 Objective
0
10
20
30
40
50
1981 83 85 87 89 91 93 95 97 99 2001
Primary and secondary syphilis — Rates by sex: United States, 1981–2001 and the Healthy People year 2010 objective
Rate (per 100,000 population)
MaleFemale2010 Objective
0
5
10
15
20
25
1981 83 85 87 89 91 93 95 97 99 2001
Primary and secondary syphilis — Rates by race and ethnicity: United States, 1981–2001 and the Healthy People year 2010
objective
Rate (per 100,000 population)
WhiteBlackHispanicAsian/Pac IslAm Ind/AK Nat2010 Objective
0
30
60
90
120
150
1981 83 85 87 89 91 93 95 97 99 2001
Primary and secondary syphilis — Male to female rate ratios: United States, 1981–2001
Male-Female rate ratio
0
1:1
2:1
3:1
4:1
5:1
1981 83 85 87 89 91 93 95 97 99 2001
Primary and secondary syphilis — Age- and sex-specific rates: United States, 2001
Men Rate (per 100,000 population) Women
Age7.5 6.0 4.5 3.0 1.5 0.0 0.0 1.5 3.0 4.5 6.0 7.5
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-140.0
Men Rate (per 100,000 population) Women
Age7.5 6.0 4.5 3.0 1.5 0.0 0.0 1.5 3.0 4.5 6.0 7.5
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14
1.4
Men Rate (per 100,000 population) Women
Age7.5 6.0 4.5 3.0 1.5 0.0 0.0 1.5 3.0 4.5 6.0 7.5
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14
5.0
Men Rate (per 100,000 population) Women
Age7.5 6.0 4.5 3.0 1.5 0.0 0.0 1.5 3.0 4.5 6.0 7.5
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14
5.9
Men Rate (per 100,000 population) Women
Age7.5 6.0 4.5 3.0 1.5 0.0 0.0 1.5 3.0 4.5 6.0 7.5
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14
6.4
Men Rate (per 100,000 population) Women
Age7.5 6.0 4.5 3.0 1.5 0.0 0.0 1.5 3.0 4.5 6.0 7.5
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14
7.2
Men Rate (per 100,000 population) Women
Age7.5 6.0 4.5 3.0 1.5 0.0 0.0 1.5 3.0 4.5 6.0 7.5
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14
5.3
Men Rate (per 100,000 population) Women
Age7.5 6.0 4.5 3.0 1.5 0.0 0.0 1.5 3.0 4.5 6.0 7.5
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14
3.4
Men Rate (per 100,000 population) Women
Age7.5 6.0 4.5 3.0 1.5 0.0 0.0 1.5 3.0 4.5 6.0 7.5
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14
1.4
Men Rate (per 100,000 population) Women
Age7.5 6.0 4.5 3.0 1.5 0.0 0.0 1.5 3.0 4.5 6.0 7.5
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14
0.4
Men Rate (per 100,000 population) Women
Age7.5 6.0 4.5 3.0 1.5 0.0 0.0 1.5 3.0 4.5 6.0 7.5
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14
3.0
Men Rate (per 100,000 population) Women
Age7.5 6.0 4.5 3.0 1.5 0.0 0.0 1.5 3.0 4.5 6.0 7.5
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14 0.2
Men Rate (per 100,000 population) Women
Age7.5 6.0 4.5 3.0 1.5 0.0 0.0 1.5 3.0 4.5 6.0 7.5
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14
2.5
Men Rate (per 100,000 population) Women
Age7.5 6.0 4.5 3.0 1.5 0.0 0.0 1.5 3.0 4.5 6.0 7.5
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14
3.8
Men Rate (per 100,000 population) Women
Age7.5 6.0 4.5 3.0 1.5 0.0 0.0 1.5 3.0 4.5 6.0 7.5
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14
3.1
Men Rate (per 100,000 population) Women
Age7.5 6.0 4.5 3.0 1.5 0.0 0.0 1.5 3.0 4.5 6.0 7.5
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14
3.0
Men Rate (per 100,000 population) Women
Age7.5 6.0 4.5 3.0 1.5 0.0 0.0 1.5 3.0 4.5 6.0 7.5
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14
2.9
Men Rate (per 100,000 population) Women
Age7.5 6.0 4.5 3.0 1.5 0.0 0.0 1.5 3.0 4.5 6.0 7.5
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14
2.0
Men Rate (per 100,000 population) Women
Age7.5 6.0 4.5 3.0 1.5 0.0 0.0 1.5 3.0 4.5 6.0 7.5
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14
0.9
Men Rate (per 100,000 population) Women
Age7.5 6.0 4.5 3.0 1.5 0.0 0.0 1.5 3.0 4.5 6.0 7.5
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14
0.2
Men Rate (per 100,000 population) Women
Age7.5 6.0 4.5 3.0 1.5 0.0 0.0 1.5 3.0 4.5 6.0 7.5
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14
0.0
Men Rate (per 100,000 population) Women
Age7.5 6.0 4.5 3.0 1.5 0.0 0.0 1.5 3.0 4.5 6.0 7.5
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14
1.4
Congenital syphilis — Rates for infants <1 year of age: United States, 1981–2001 and the Healthy People year 2010 objective
Rate (per 100,000 live births)
Cong. Syphilis2010 Objective
0
25
50
75
100
125
1981 83 85 87 89 91 93 95 97 99 2001
Note: The Healthy People 2010 (HP2010) objective for primary and secondary syphilis is 0.2 case per 100,000 population. The surveillance case definition for congenital syphilis changed in 1988.
Other Sexually Transmitted Diseases
Sexually Transmitted Disease Surveillance 2001
Division of STD Prevention
Chancroid — Reported cases: United States, 1981–2001
Cases (in thousands)
0
1
2
3
4
5
1981 83 85 87 89 91 93 95 97 99 2001
Genital herpes — Initial visits to physicians’ offices: United States, 1966–2001
Visits (in thousands)
0
50
100
150
200
250
1966 69 72 75 78 81 84 87 90 93 96 99
SOURCE: National Disease and Therapeutic Index (IMS America, Ltd.)
Genital herpes simplex virus type 2 infections — Percent seroprevalence according to age in NHANES* II (1976-1980) and
NHANES III (1988-1994)
Percent
NHANES IINHANES III
0
8
16
24
32
40
Age Group
12-19 20-29 30-39 40-49 50-59 60-69 70+
Note: Bars indicate 95% confidence intervals.
*National Health and Nutrition Examination Survey
Genital warts — Initial visits to physicians’ offices: United States, 1966–2001
Visits (in thousands)
0
80
160
240
320
400
1966 69 72 75 78 81 84 87 90 93 96 99
SOURCE: National Disease and Therapeutic Index (IMS America, Ltd.)
Nonspecific urethritis — Initial visits to physicians’ offices by men:United States, 1966–2001
Visits (in thousands)
0
80
160
240
320
400
1966 69 72 75 78 81 84 87 90 93 96 99
SOURCE: National Disease and Therapeutic Index (IMS America, Ltd.)